We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Software Automatically Flags Suspected PEs in CT Images

By MedImaging International staff writers
Posted on 31 May 2022
Print article
Image: FDA clearance for Rapid PE triage & notification (Photo courtesy of RapidAI)
Image: FDA clearance for Rapid PE triage & notification (Photo courtesy of RapidAI)

Over the last decade, death rates for pulmonary embolism (PE) have been on the rise, with the biggest increase among people under 65 years. For those who experience and survive a PE incident, one-third will have a recurrence within 10 years. Increasing access to clinically validated technology will be the key to helping hospitals more efficiently coordinate care, make accurate diagnoses in a timely manner, and get PE patients to treatment faster, leading to better outcomes. Now, a new clinically driven AI platform enables fast identification and communication of suspected central PE, extending the physicians’ ability to prioritize patients, reduce time to treatment and improve patient outcomes.

Modernizing PE care management means driving clinical, operational and financial efficiency. RapidAI (San Mateo, CA, USA) offers RapidAI solution for PE, a suite of products and services, that enables care teams to reach a new level of efficiency by leveraging technology to accelerate decision making and streamline the PE patient workflow. RapidAI solution for PE includes Rapid PE Triage & Notification, an AI-based clinical decision support tool that automatically identifies and sends notifications of suspected central PE on CTPA images - enabling teams to prioritize and accelerate time to treatment.

Getting the right physicians and team members aligned quickly means less time repeating information and more time diagnosing and treating patients. RapidAI solution for PE also includes Rapid Workflow for PE that modernizes workflow for easier care coordination and more efficient team communication. Physicians can preview CTPA images anywhere at any time via a mobile device, desktop or laptop. HIPAA-compliant messaging allows team members stay up to date on new cases, images and patient status. RapidAI has received FDA 510(k) clearance for its Rapid PE Triage & Notification product.

Rapid PE Triage & Notification, in conjunction with Rapid Workflow for PE, will enable care teams to more easily manage the entire patient care journey, from the moment a suspected PE patient is identified to diagnosis and through treatment. By automatically identifying a suspected PE and delivering real-time notifications to physicians, patients can be triaged faster and care teams aligned more quickly, reducing overall time to treatment.

“Building on our expertise in stroke, we’re confident this technology will help modernize PE care and meaningfully improve patient outcomes,” said Karim Karti, CEO of RapidAI. “Our goal is to build solutions that address the specific challenges associated with treating various conditions, as well as the communication and workflow issues faced by hospitals globally. From stroke to aneurysm to PE, we’re proud of how much RapidAI has grown and are excited to continue to redefine the patient care journey.”

Related Links:
RapidAI

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Breast Imaging Workstation
SecurView
New
Ultrasound System
Acclarix AX9
New
Portable Radiology System
DRAGON ELITE & CLASSIC

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.